Journal profile · CARDIAC & CARDIOVASCULAR SYSTEMS
Rational Pharmacotherapy in Cardiology
ISSN 1819-6446 · eISSN 2225-3653 · Stolichnaya Izdatelskaya Kompaniya · Russian Federation
Rational Pharmacotherapy in Cardiology: CAS Zone 4 · Medicine (2025 upgraded edition); diamond open access (no APC); no APC; review about 6 weeks (community reports); 49 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Rational Pharmacotherapy in Cardiology is published by Stolichnaya Izdatelskaya Kompaniya and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Healthcare Systems and Public Health, Blood Pressure and Hypertension Studies and Atrial Fibrillation Management and Outcomes, together about 32.1% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The most important tasks of the journal are the generalization of scientific and practical achievements in the field of pharmacotherapy and prevention of diseases of the cardiovascular system, advanced training of cardiologists and therapists. The scientific concept of the publication involves the publication of materials on modern achievements in the field of cardiology, the results of national and international clinical trials. The journal publishes articles based on the results of original clinical studies aimed at studying the effectiveness and safety of medicines, analysis of clinical practice, its compliance with national and international recommendations, opinions of specialists on a wide range of issues of cardiology, associated conditions and clinical pharmacology. To stimulate interest in research in the extremely popular field of preventive cardiology and public health, there is a rubric with a similar name. The section "Our Teachers" publishes memoirs of outstanding figures of medicine and cardiology, which is of interest to medical historians. The editorial board of the journal pays great attention to the issues of constructive reviewing and editing of manuscripts, considering it as an important educational mission.
From the journal's Aims & Scope
Research area (LetPub): CARDIAC & CARDIOVASCULAR SYSTEMS
Editor-in-chief Oxana M. DrapkinaPublisher website
Editorial board by country: none in mainland China; most named Russia 48, Finland 2, India 1, Greece 1 (52 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Healthcare Systems and Public HealthMedicine13.4%
- Blood Pressure and Hypertension StudiesMedicine10.1%
- Atrial Fibrillation Management and OutcomesMedicine8.6%
- Neurological Disorders and TreatmentsNeuroscience7.6%
- Lipoproteins and Cardiovascular HealthMedicine5.2%
- Acute Myocardial Infarction ResearchMedicine4.6%
- Cardiac Imaging and DiagnosticsMedicine4.5%
- Antiplatelet Therapy and Cardiovascular DiseasesMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SCIEWeb of SciencePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2023
- 1.02Publisher website ·
- CiteScore 2026-06
- 1.3LetPub ·
- SJR 2026-06
- 0.17LetPub ·
- SNIP 2026-06
- 0.31LetPub ·
- h-index
- 29OpenAlex ·
- i10-index
- 135OpenAlex ·
- 2-year mean citedness
- 0.76OpenAlex ·
- Self-citation rate
- 50%LetPub ·
- Share of gold OA articles
- 93.55%LetPub ·
Volume
- Articles per year
- 69LetPub ·
Articles by year OpenAlex count · 2,118 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 59 | 59 | 18 |
| 2025 | 49 | 49 | 31 |
| 2024 | 74 | 74 | 89 |
| 2023 | 96 | 96 | 190 |
| 2022 | 93 | 93 | 387 |
| 2021 | 101 | 101 | 369 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 6 weeksLetPub ·
- Submission to publication (journal-reported)
- about 6 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted8
- descriptions of case studiesdescriptions of case studiesLength not stated
- editorialseditorialsLength not stated
- experimental studies of clinical relevanceexperimental studies of clinical relevanceLength not stated
- expert discussionsexpert discussionsLength not stated
- guidelines and consensus documentsguidelines and consensus documentsLength not stated
- letters to the editorletters to the editorLength not stated
- original clinical studiesincluding original clinical studiesLength not stated
- reviewPasteurised Akkermansia muciniphila in obesity and metabolic syndrome: mechanisms of action and clinical potential G. E. Leonov, A. V. Starodubova PDF (Rus) HTM…Length not stated
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Peer review, Plagiarism, Preprints
- AI use The attitude to the use of artificial intelligence (AI) in scientific activity
The attitude of a scientific peer-reviewed journal to the use of artificial intelligence (AI) in scientific activity, in particular, when creating a manuscript of a scientific article by one author or a team of authors General definitions Any activity (human activity) is characterized by the influence of the subject on the object with the definition of a aim and plan. The subject (person) carries …
Source ↗Publisher website ·- Conflicts of interest 2.2.5. Conflict of interest information.
This section should contain information on the possible relationship of each of the authors with industrial and financial organizations, which may cause a conflict of interest in connection with the material presented in the manuscript.
Source ↗Publisher website ·- License & copyright Copyright Notice
Authors retain copyright; CC Attribution License Model summary
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, addition…
Source ↗Publisher website ·- Open access Open Access Policy
"Rational Pharmacotherapy in Cardiology" is an open access journal. All articles are made freely available to readers immediatly upon publication. Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition - it means that articles have free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link t…
Source ↗Publisher website ·- Peer review Peer Review Process
Double blind peer review Model summary
Members of the editorial board and leading Russian and international experts in corresponding areas of life sciences, invited as independent readers, perform peer reviews. Editor-in-Chief, Deputy editor-in-chief or Science editor choose readers for peer review. We aim to limit the review process to 2-4 weeks, though in some cases the schedule may be adjusted at the reviewer’s request.Reviewer has …
Source ↗Publisher website ·- Plagiarism Plagiarism detection
Original, unpublished work only Model summary
"Rational Pharmacotherapy in Cardiology" use native russian-language plagiarism detection software Antiplagiat to screen the submissions. If plagiarism is identified, the COPE guidelines on plagiarism will be followed.
Source ↗Publisher website ·- Preprints Preprint and postprint Policy
Preprint posting permitted and encouraged Model summary
In the process of submitting an article, the author must confirm that the article has not been published or has not been accepted for publication in another scientific journal. When referring to an article published in the journal "Rational Pharmacotherapy in Cardiology", the publisher asks you to post a link (full URL of the material) to the official website of the journal. Articles previously pu…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Stolichnaya Izdatelskaya Kompaniya
- Country or region
- Russian Federation
- Language
- English, Russian
- ISSN
- 1819-6446
- Electronic ISSN
- 2225-3653
- Latest issue on the website
- Volume 22, Issue 3 (2026)
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Rational Pharmacotherapy in Cardiology
What CAS zone is Rational Pharmacotherapy in Cardiology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Rational Pharmacotherapy in Cardiology is in Zone 4 of Medicine, and in Zone 4 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Rational Pharmacotherapy in Cardiology?
Authors report an average review time of about 6 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Rational Pharmacotherapy in Cardiology based?
Of the 52 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Russia (48), Finland (2) and India (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Rational Pharmacotherapy in Cardiology?
According to LetPub and DOAJ records, Rational Pharmacotherapy in Cardiology is indexed in ESCI, Scopus and DOAJ. The journal's website also lists SCIE and Web of Science; that list has not been checked against each database.
Is Rational Pharmacotherapy in Cardiology open access, and what is the APC?
Rational Pharmacotherapy in Cardiology is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .